Novolog Pharm-Up 1966 Ltd
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Health Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation proces… Read more
Novolog Pharm-Up 1966 Ltd (NVLG) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.040x
Based on the latest financial reports, Novolog Pharm-Up 1966 Ltd (NVLG) has a cash flow conversion efficiency ratio of 0.040x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA15.42 Million) by net assets (ILA384.05 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Novolog Pharm-Up 1966 Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Novolog Pharm-Up 1966 Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Novolog Pharm-Up 1966 Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novolog Pharm-Up 1966 Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Carmat SA
F:CXT
|
0.300x |
|
Modern Healthcare Technology Holdings Limited
F:M3L
|
0.149x |
|
Correlate Infrastructure Partners Inc
OTCQB:CIPI
|
-0.123x |
|
Topvision Eye Specialist Berhad
KLSE:0332
|
N/A |
|
Urban-Gro Inc
NASDAQ:UGRO
|
0.056x |
|
Coca Cola HBC AG
LSE:CCH
|
0.256x |
|
Star Navigation Systems Group Ltd
PINK:SNAVF
|
0.140x |
|
Carmel Corp Ltd.
TA:CRML
|
0.036x |
Annual Cash Flow Conversion Efficiency for Novolog Pharm-Up 1966 Ltd (2014–2024)
The table below shows the annual cash flow conversion efficiency of Novolog Pharm-Up 1966 Ltd from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA382.14 Million | ILA158.52 Million | 0.415x | -17.85% |
| 2023-12-31 | ILA396.12 Million | ILA200.01 Million | 0.505x | +75.88% |
| 2022-12-31 | ILA462.05 Million | ILA132.65 Million | 0.287x | +48.12% |
| 2021-12-31 | ILA430.23 Million | ILA83.39 Million | 0.194x | -2.01% |
| 2020-12-31 | ILA295.67 Million | ILA58.48 Million | 0.198x | -48.57% |
| 2019-12-31 | ILA263.78 Million | ILA101.45 Million | 0.385x | +63.10% |
| 2018-12-31 | ILA101.61 Million | ILA23.96 Million | 0.236x | -76.60% |
| 2017-12-31 | ILA85.71 Million | ILA86.37 Million | 1.008x | +251.15% |
| 2016-12-31 | ILA70.68 Million | ILA20.28 Million | 0.287x | -79.07% |
| 2015-12-31 | ILA102.34 Million | ILA140.29 Million | 1.371x | -25.93% |
| 2014-12-31 | ILA86.77 Million | ILA160.59 Million | 1.851x | -- |